Over expression of catalase, superoxide dismutase 1 in the lungs and liver of treated group. Attenuation of the right ventricular hypertrophy. Upregulation of hepatic and pulmonary antioxidant genes. This evidence concerns the gene SOD1 and Right ventricular hypertrophy.